Edition:
United States

Karo Pharma AB (KARO.ST)

KARO.ST on Stockholm Stock Exchange

25.50SEK
23 May 2018
Change (% chg)

-- (--)
Prev Close
25.50kr
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
446,250
52-wk High
41.68kr
52-wk Low
25.30kr

Select another date:

Mon, Apr 30 2018

BRIEF-Karo Pharma Determines Terms For Rights Issue

* THE TERMS FOR KARO PHARMA'S RIGHTS ISSUE HAVE BEEN DETERMINED

BRIEF-Karo Pharma Q1 EBITDA rose to SEK 89 mln

* KARO PHARMA DOUBLES SALES AND EARNINGS IN THE FIRST QUARTER

BRIEF-Karo Pharma: Board Of Directors Resolves On Fully Guaranteed Rights Issue

* THE BOARD OF DIRECTORS OF KARO PHARMA HAS RESOLVED ON A FULLY GUARANTEED RIGHTS ISSUE SUBJECT TO APPROVAL BY THE ANNUAL GENERAL MEETING

BRIEF-Karo Pharma Intends To Propose Dividend Of SEK 0.30 Per Share

* INTENDS TO PROPOSE DIVIDEND OF SEK 0.30 PER SHARE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Karo Pharma Acquires Major Product Portfolio for EUR 260 Mln

* ‍ACQUIRES A PRODUCT PORTFOLIO FROM DANISH PHARMACEUTICAL COMPANY LEO PHARMA A/S FOR 260 MEURO​

BRIEF-Karo Pharma AB Q4 Adjusted EBITDA Rises To SEK 41.8 Mln

* Q4 NET SALES SEK 238.7 MILLION VERSUS SEK 96.5 MILLION YEAR AGO

BRIEF-Karo Pharma Says RORgamma Project Is Not Shut Down

* SAYS RORGAMMA PROJECT IS NOT SHUT DOWN BUT CARRIES ON AS PLANNED Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Karo Pharma Rights Issue Subscribed To 170 Percent

* RIGHTS ISSUE SUBSCRIBED TO 170 PERCENT WITH PROCEEDS AT ABOUT SEK 794.3 MILLION BEFORE ISSUE COSTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Karo Pharma: New Issue To Provide Up To SEK 794.3 Ml‍n Before Issue Costs

* SAYS NEW ISSUE TO PROVIDE UP TO SEK 794.3 ML‍N BEFORE ISSUE COSTS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Karo Pharma Chairman Called For Inquiry For Inside Trading

* CHAIRMAN CALLED IN TO INQUIRY FROM POLICE FOR INSIDE TRADING

Select another date: